What is he best known for?
The fields of study he is best known for:
Philippe Langella mainly focuses on Microbiology, Immunology, Dysbiosis, Faecalibacterium prausnitzii and Colitis.
His Microbiology research is multidisciplinary, incorporating elements of Gut flora, Lactococcus lactis, Inflammatory bowel disease, Immune system and Bacteria.
His Immunology study incorporates themes from Probiotic, Ovarian cancer and Intestinal mucosa.
As a part of the same scientific study, Philippe Langella usually deals with the Probiotic, concentrating on Firmicutes and frequently concerns with Peripheral blood mononuclear cell.
His Faecalibacterium prausnitzii research incorporates elements of Acute colitis, Human microbiome and In vivo.
His biological study deals with issues like Interleukin 10, which deal with fields such as Chemokine, Elafin, Ovalbumin and T cell.
His most cited work include:
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients (2626 citations)
- Microbial dysbiosis in colorectal cancer (CRC) patients. (525 citations)
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands (514 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Microbiology, Lactococcus lactis, Immunology, Bacteria and Probiotic.
His research integrates issues of Dysbiosis, Colitis, Immune system and Lactobacillus in his study of Microbiology.
Philippe Langella has researched Lactococcus lactis in several fields, including Plasmid, Recombinant DNA, Biochemistry, Antigen and Molecular biology.
His Recombinant DNA study combines topics in areas such as Fibronectin binding protein A and In vivo.
His Immunology research is multidisciplinary, incorporating perspectives in Intestinal mucosa and Inflammatory bowel disease.
The Faecalibacterium prausnitzii study combines topics in areas such as Crohn's disease, Internal medicine, Anti-inflammatory and Gastroenterology.
He most often published in these fields:
- Microbiology (79.18%)
- Lactococcus lactis (41.30%)
- Immunology (34.81%)
What were the highlights of his more recent work (between 2016-2021)?
- Microbiology (79.18%)
- Probiotic (21.50%)
- Gut flora (14.33%)
In recent papers he was focusing on the following fields of study:
Philippe Langella mainly investigates Microbiology, Probiotic, Gut flora, Immunology and Lactococcus lactis.
The various areas that Philippe Langella examines in his Microbiology study include Colitis, Bacteria, Biofilm, Immune system and Escherichia coli.
His research in Probiotic intersects with topics in Commensalism, Biotechnology and In vitro.
Many of his research projects under Gut flora are closely connected to Aryl hydrocarbon receptor with Aryl hydrocarbon receptor, tying the diverse disciplines of science together.
His research in Immunology focuses on subjects like Inflammatory bowel disease, which are connected to Intestinal mucosa.
His Lactococcus lactis research integrates issues from Plasmid, Bifidobacterium longum and Recombinant DNA.
Between 2016 and 2021, his most popular works were:
- Fungal microbiota dysbiosis in IBD (433 citations)
- Towards standards for human fecal sample processing in metagenomic studies (259 citations)
- Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria (225 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Microbiology, Dysbiosis, Bacteria, Gut flora and Probiotic.
His Microbiology study combines topics from a wide range of disciplines, such as Immune system, Colitis, Immunology, Lactococcus lactis and Saccharomyces boulardii.
In his research on the topic of Immune system, Faecalibacterium prausnitzii is strongly related with NF-κB.
His Immunology study focuses on Inflammation in particular.
Philippe Langella combines subjects such as Butyrate and Gastrointestinal Microbiome with his study of Bacteria.
His Gut flora research is multidisciplinary, relying on both Endocrinology, Internal medicine, Metabolic syndrome, Lactobacillus rhamnosus and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
